EGFR and malignant colon neoplasm: Although C1GALT1 controls many cellular behaviors and EGFR serves as a therapeutic target in several malignancies, including HNSCC, lung cancers, and colon cancers, the therapeutic potential of targeting C1GALT1 and its effect on EGFR signaling in HNSCC remain unclear.